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Recent studies have shown that G-protein-coupled re-
ceptors (GPCRs) can assemble as high molecular weight
homo- and hetero-oligomeric complexes. This can result
in altered receptor-ligand binding, signaling, or intra-
cellular trafficking. We have co-transfected HEK-293
cells with differentially epitope-tagged GPCRs from dif-
ferent subfamilies and determined whether oligomeric
complexes were formed by co-immunoprecipitation and
immunoblot analysis. This gave the surprising result
that the 5HT1A receptor was capable of forming hetero-
oligomers with all GPCRs tested including the 5HT1B,
5HT1D, EDG1, EDG3, GPR26, and GABAB2 receptors. The
testing of other GPCR combinations showed similar re-
sults with hetero-oligomer formation occurring for the
5HT1D with the 5HT1B and EDG1 receptor. Control stud-
ies showed that these complexes were present in co-
transfected cells before the time of lysis and that the
hetero-oligomers were comprised of GPCRs at discrete
stoichiometries. These findings suggest that GPCRs
have a natural tendency to form oligomers when co-
transfected into cells. Future studies should therefore
investigate the presence and physiological role of GPCR
hetero-oligomers in cells in which they are endog-
enously expressed.
Recent studies have shown that G-protein-coupled receptors
(GPCRs)1 may form dimers or higher order oligomers (1–7).
This has led to some re-evaluation of the mechanisms thought
to be involved in GPCR function. Co-expression studies with
chimeric 2C-adrenergic/M3 muscarinic receptor constructs
have shown that intermolecular interactions can occur between
different GPCR subtypes (1, 2). More direct studies have shown
that the GABABR1 and GABABR2 receptors are not functional
as separate units and can only form a functional receptor
complex with the correct pharmacological properties and
plasma membrane expression when they are co-expressed (8–
12). The finding that co-transfection of the  and  opioid
receptors results in the formation of heterodimers with ligand
binding and functional properties that are distinct from singly
transfected receptors suggests that heterodimerization may be
involved in modulation of GPCR function (13). Also, Western
blot studies have shown that the 5HT1D and 5HT1B receptors
form homodimers when expressed alone although they prefer-
entially form heterodimers when co-expressed (14). In the pres-
ent study, we have directly examined whether 5HT1 receptors
are capable of forming oligomeric complexes with a variety of
GPCRs by specific immunoprecipitation of each receptor fol-
lowed by identification of the co-precipitated proteins using
immunoblot analysis. The main objective was to determine the
specificity of the interactions across different GPCR subfami-
lies to gain further insight into the mechanism of GPCR
hetero-oligomerization.
EXPERIMENTAL PROCEDURES
Materials—Restriction endonucleases and other DNA-modifying en-
zymes were from New England Biolabs (Beverly, MA) or Amersham
Biosciences. Dulbecco’s modified Eagle’s medium and fetal calf serum
were from Invitrogen. All other biochemicals were obtained from Sigma
unless specified otherwise.
Construction of Epitope-tagged GPCRs and Transient Transfec-
tions—The c-Myc epitope (EQKLISEEDL) was inserted at the amino
termini of 5HT1A and 5HT1D receptors by PCR mutagenesis using a
Stratagene Robocycler with Hot-Top assembly (Amsterdam, Holland)
as described by Nelson and Long (15). The FLAG epitope (DYKDDDDK)
was inserted by a similar procedure into the amino termini of 5HT1A,
5HT1B, 5HT1D, EDG1, and EDG2 receptors. FLAG-tagged EDG3, GPR26,
and GABAB2 receptors were a gift from Dr. Kevin Lynch (University of
Virginia, Charlottesville, VA). PCR products were cloned into the eu-
caryotic expression vector pCDNA3.1 (Invitrogen) using standard
techniques (16). Inserts were sequenced with an ABI Prism dye termi-
nator cycle sequencing kit and analyzed on an Applied Biosystems 373A
stretch DNA sequencer. Transient transfection of HEK-293 cells with
the epitope-tagged constructs was performed by calcium phosphate-
mediated gene transfer as described previously (17).
Immunoprecipitation—Forty-eight hours after transfection cells
were washed three times in phosphate-buffered saline, harvested by
scraping, and centrifuged for 5 min at 500  g. The pelleted cells were
homogenized at 4 °C by drawing up and down through a 20-gauge
syringe needle in 1 ml of cell lysis buffer (Sigma). The homogenates
were centrifuged for 20 min at 14,000  g at 4 °C, and the supernatants
were combined with 12.5 l (packed gel) of either anti-c-Myc or anti-
FLAG M2 affinity agarose (Sigma) and mixed overnight at 4 °C. The
immunoadsorbents were recovered by centrifugation for 5 min at 700 
g and washed three times by resuspension and centrifugation (5 min at
700  g) in cell lysis buffer and two times in 50 mM Tris (pH 7.5)
containing 0.1% (w/v) SDS and 150 mM NaCl. The samples were eluted
into 60 l of SDS loading buffer (Sigma).
Immunoblot Analysis—Eluted samples were heated for 3 min at
100 °C and subjected to SDS-PAGE on slab gels (180  160  1.5 mm)
polymerized from 10% (w/v) acrylamide and 0.1% N,N-methylenebisac-
rylamide in Tris/glycine/SDS buffer (Novex, San Diego, CA) using the
discontinuous buffer system of Laemmli (18). The electrophoresed pro-
teins were subjected to semi-dry electrophoretic transfer onto polyvi-
nylidene difluoride membranes as described previously (19). The mem-
branes were incubated with either mouse c-Myc antibodies (1:1000) or
mouse FLAG antibodies (1:1000) and then with peroxidase-conjugated
sheep anti-mouse serum (1:1000) for detection of immunoreactive bands
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by enhanced chemiluminescence (Amersham Biosciences). Molecular
size calibration was achieved with the MultiMark standards (Novex).
RESULTS
Homo-oligomerization of 5HT1A, 5HT1B, and 5HT1D Recep-
tors—HEK-293 cells transfected with either FLAG-tagged
5HT1A, 5HT1B, or 5HT1D receptor constructs were immunopre-
cipitated with anti-FLAG-agarose, and immunoblot analysis of
the precipitates revealed the presence of 46, 44, and 42-kDa
FLAG-immunoreactive bands, respectively (Fig. 1A). Higher
molecular weight immunoreactive forms were also present,
which might represent oligomeric forms of the 5HT1 receptors.
An immunoreactive band that migrated at a size predicted for
a FLAG-tagged 5HT1A receptor dimer (92 kDa) showed a
strong increase in immunostaining with the reciprocal de-
crease of the 46-kDa monomer band when the disulfide bond-
reducing agent dithiothreitol was omitted from the sample
loading buffer (Fig. 1B). An immunoreactive band that mi-
grated at a size predicted for a FLAG-tagged 5HT1B receptor
dimer (88 kDa) showed increased immunostaining with the
loss of the 44-kDa monomer band when the samples were
electrophoresed in the absence of dithiothreitol (Fig. 1B). Sim-
ilarly, a possible FLAG-tagged 5HT1D receptor dimer (82 kDa)
showed an increase in immunostaining on non-reducing gels
with the reciprocal disappearance of the 41-kDa monomer band
(Fig. 1B). Similar results have been shown previously for the
5HT1B and 5HT1D receptors, which led to the suggestion that
they form homodimers (14). The mechanism of 5HT1B receptor
homodimerization appeared to differ from that of the 5HT1A
and 5HT1D receptors because a high proportion 5HT1B receptor
homodimer was observed even when gels were run under di-
sulfide bond-reducing conditions (Fig. 1A).
Hetero-oligomerization of 5HT1A and 5HT1D Receptors with
Other GPCRs— To directly test for hetero-oligomerization of
different GPCR combinations we used sequential co-immuno-
precipitation and immunoblot analyses of cells co-transfected
with differentially epitope-tagged receptors. This showed that
the c-Myc-tagged 5HT1A receptor co-precipitated with FLAG-
tagged versions of all receptors tested including the 5HT1A,
5HT1B, 5HT1D, EDG1, EDG3, GPR26, and GABAB2 receptors
(Fig. 2, A and B). The same finding was observed for the
c-Myc-tagged 5HT1D receptor, which was co-precipitated with
FLAG-tagged versions of the 5HT1B and EDG1 receptors (Fig.
2, A and B). Previous studies have also shown that the 5HT1B
and 5HT1D receptors form heterodimers (14). The finding that
the FLAG- and c-Myc-tagged versions of the 5HT1A receptor
were co-precipitated provides direct evidence that this GPCR
forms a homo-oligomer. This was also found for the 5HT1D
receptor using the c-Myc- and FLAG-tagged versions of this
GPCR (data not shown). Co-precipitation of high molecular
weight FLAG-immunoreactive 5HT1B, 5HT1D, EDG1, and
EDG3 species with the c-Myc-5HT1A receptor (Fig. 2A) suggests
that these GPCRs might be present as homodimers and trimers
in higher order hetero-oligomeric complexes comprised of at
least one c-Myc-5HT1A receptor and two or more of the FLAG-
tagged constructs.
Sequential Immunoprecipitation/Immunoblot Analysis of
Mixed Singly Transfected HEK-293 Cells—To rule out the pos-
sibility that the observed hetero-oligomerizations were caused
by nonspecific aggregation of receptors, extracts from cells sep-
arately expressing the c-Myc-tagged 5HT1A and FLAG-tagged
5HT1B receptors were mixed, immunoprecipitated with anti-c-
FIG. 1. Immunoblot analysis of transfected HEK-293 cells showing homo-oligomerization of 5HT1A, 5HT1B, and 5HT1D receptors. A,
HEK-293 cells (5  107) expressing the FLAG-tagged 5HT1A (lane 1), 5HT1B (lane 2), or 5HT1D receptor (lane 3) were immunoprecipitated and
subjected to immunoblot analysis using FLAG antibodies as described under “Experimental Procedures.” B, the same immunoprecipitated samples
were subjected to immunoblot analysis under non-reducing (minus dithiothreitol) conditions. The migration of monomers is indicated by open
arrows (approximate molecular sizes are: 5HT1A, 46 kDa; 5HT1B, 44 kDa; 5HT1D, 42 kDa), the putative dimers are indicated by solid arrows, and
immunoglobulin heavy chains are indicated by an arrowhead. The molecular size markers are shown in kDa. The immunoblots shown are
representative of at least three independent experiments.
FIG. 2. Sequential immunoprecipitation/immunoblot analysis
of transfected HEK-293 cells showing oligomerization of 5HT1A
and 5HT1D receptors with other GPCRs. HEK-293 cells (5  10
7)
either co-expressing the c-Myc-tagged 5HT1A receptor with FLAG-
tagged versions of the 5HT1A (lane 1), 5HT1B (lane 2), 5HT1D (lane 3),
EDG1 (lane 4), EDG3 (lane 5), GPR26 (lane 6), and GABAB2 (lane 7)
receptors or co-expressing the c-Myc-tagged 5HT1D receptor with
FLAG-tagged versions of the 5HT1B (lane 8) and EDG1 (lane 9) recep-
tors were immunoprecipitated using either anti-c-Myc (A) or anti-
FLAG-agarose (B), and the precipitates were subjected to immunoblot
analysis using FLAG (A) or c-Myc (B) antibodies as described under
“Experimental Procedures.” The molecular size markers are shown in
kDa (approximate molecular sizes are: 5HT1A, 46 kDa; 5HT1B, 44 kDa;
5HT1D, 42 kDa; EDG1, 43 kDa; EDG3, 42 kDa; GPR26, 38 kDa; GABAB2,
106 kDa). The immunoblots shown are representative of four independ-
ent experiments. IP, immunoprecipitate.
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Myc agarose, and subjected to immunoblot analysis with FLAG
antibodies. In this case, the FLAG-5HT1B receptor was not
detected in the precipitated material (Fig. 3A). Similarly, im-
munoprecipitation of the mixed extract with anti-FLAG agar-
ose followed by immunoblot analysis with c-Myc antibodies did
not detect the c-Myc-5HT1A receptor (Fig. 3B). This confirmed
that successful immunoprecipitation of 5HT1A/5HT1B hetero-
oligomers requires co-expression within the same cells before
the time of lysis. Thus, the oligomerization of the c-Myc-tagged
5HT1A and FLAG-tagged 5HT1B receptors in the present study
is not likely to be caused by nonspecific aggregation. The same
results were found for all of the other GPCR/GPCR hetero-
oligomers tested in this study (data not shown).
Sequential Immunoprecipitation/Immunoblot Analysis of
HEK-293 Cells Transfected with Varying Amounts of 5HT1A
and EDG1 Receptors—To determine whether the hetero-oli-
gomers observed in this study are comprised of GPCRs at
discrete protein/protein ratios, HEK-293 cells were co-trans-
fected with a fixed amount (25 g) of the c-Myc-tagged 5HT1A
receptor and varying amounts (25, 5, 1, and 0.2 g) of the
FLAG-tagged EDG1 receptor. The relative amounts of the
c-Myc-5HT1A receptor that were associated with the decreasing
levels of the FLAG-EDG1 receptor were determined by sequen-
tial immunoprecipitation and immunoblot analysis. Immuno-
precipitation of the FLAG-EDG1 receptor with anti-FLAG-aga-
rose resulted in co-precipitation of similar decreasing levels of
c-Myc-5HT1A receptor (Fig. 4B) as shown by immunoblot anal-
ysis with c-Myc antibodies. Similarly, immunoprecipitation of
the c-Myc-5HT1A receptor resulted in co-precipitation of de-
creasing levels of the FLAG-EDG1 receptor (Fig. 4D). Sequen-
tial immunoprecipitation/immunoblot analysis of the lysates
with c-Myc/c-Myc or FLAG/FLAG confirmed that the c-Myc-
5HT1A receptor was actually expressed in the cells at relatively
constant levels and that expression of the FLAG-EDG1 receptor
decreased accordingly with the amounts of cDNA transfected
into the cells (Fig. 4, A and C). Similar results were obtained for
all of the other receptors under study (data not shown).
DISCUSSION
We have used a co-immunoprecipitation approach to provide
direct evidence that GPCRs from different subfamilies are ca-
pable of forming hetero-oligomers when co-expressed in HEK-
293 cells. Cells were co-transfected with GPCR constructs con-
taining different epitope tags followed by immunoprecipitation
of one receptor and detection of co-precipitated receptors by
immunoblot analysis. The 5HT1A receptor formed a homo-oli-
gomer when expressed alone and formed hetero-oligomers
when co-expressed with the closely related 5HT1B and 5HT1D
receptors (36% amino acid homology) and also with the more
distantly related EDG1, EDG3, GPR26, and GABAB2 receptors
(4–16% amino acid homology). Interestingly, hetero-oligomer
formation was shown for all other GPCR combinations tested
including the 5HT1D receptor with the 5HT1B and EDG1 recep-
tors. The heterodimerization of 5HT1B and 5HT1D receptors
has been shown previously in insect SF9 cells using a viral
expression system followed by Western blot analysis (14).
The results of this study suggest that the receptor complexes
were pre-existing in cells at the time of lysis and were not
caused by nonspecific aggregation. Oligomerization was ob-
served only in lysates from co-transfected cells and not in
mixed lysates from singly transfected cells. Also, the observed
receptor/receptor interactions appeared to occur at defined sto-
ichiometries in co-transfected cells because decreased expres-
sion of one receptor resulted in a similar incremental decrease
in the amount of the second receptor immunoprecipitated. The
appearance of high molecular weight immunoreactive bands
corresponding in size to 5HT1A and 5HT1D receptor homo-
oligomers appeared to require intact disulfide bonds because
these were only detected when gels were run under non-reduc-
ing conditions. Little or no 5HT1A and 5HT1D receptor homo-
oligomers could be detected when gels were run under reducing
conditions. In contrast, a significant proportion of the 5HT1B
receptor was detected as high molecular weight oligomers
when gels were run under reducing conditions with increased
levels of the oligomer and reciprocal loss of the monomer under
non-reducing conditions. This indicates that the mechanism of
5HT1B receptor homo-oligomer formation differs from that of
the 5HT1A and 5HT1D receptors. Also, the observed immuno-
isolation of the putative 5HT1B receptor dimer by immunopre-
cipitation of the 5HT1A receptor indicates that these receptors
may be present as higher order hetero-oligomers such as trim-
ers or tetramers.
A major prerequisite for the physiological assembly of het-
ero-oligomeric GPCRs is co-expression in the same cells. To
demonstrate this would require detailed immunological or spe-
cific binding experiments that localize the receptors under
study to the same cells combined with co-precipitation studies
using receptor-specific antibodies or ligands. The GPCRs tested
in this study show a wide range of tissue distributions in the
brain. Within the 5HT receptor subfamily 5HT1A, 5HT1B, and
5HT1D receptors all show pre- and postsynaptic localizations
and can be found together in some of the same brain regions
including the cortex and dorsal raphe nucleus (20–22). The
5HT1B receptor shows co-expression with the 5HT1A receptor in
FIG. 3. Sequential immunoprecipitation/immunoblot analysis
of mixed singly transfected HEK-293 cells. HEK-293 cells (5  107)
expressing either the c-Myc-tagged 5HT1A receptor (lane 1), the FLAG-
tagged 5HT1B receptor (lane 2), or a mixture of both membranes (lane 3)
were immunoprecipitated (IP) with either anti-c-Myc agarose (A and D)
or anti-FLAG agarose (B and C), and the precipitates were subjected to
immunoblot (Blot) analysis with either c-Myc (A and B) or FLAG (C and
D) antibodies as described under “Experimental Procedures.” The im-
munoblots shown are representative of at least three independent
experiments.
FIG. 4. Sequential immunoprecipitation/immunoblot analysis
of HEK-293 cells transfected with varying amounts of 5HT1A and
EDG1 receptors. HEK-293 cells (5  10
7) were co-transfected with 25
g of the c-Myc-tagged 5HT1A receptor and either 25 (lane 1), 5 (lane 2),
1 (lane 3), or 0.2 (lane 4) g of the FLAG-tagged EDG1 receptor followed
by immunoprecipitation (IP) using either anti-c-Myc agarose (A and D)
or anti-FLAG agarose (B and C), and the precipitates were subjected to
immunoblot (Blot) analysis using c-Myc (A and B) or FLAG (C and D)
antibodies as described under “Experimental Procedures.” The molec-
ular sizes of the c-Myc-5HT1A (45 kDa) and FLAG-EDG1 (42 kDa)
receptor constructs are shown. The immunoblots shown are represent-
ative of three independent experiments.
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the hippocampus and with the 5HT1D receptor in the olfactory
tubercle although the 5HT1B receptor is expressed separately
in the anterior caudate putamen, hypothalamus, and thala-
mus, and the 5HT1D receptor is localized separately in the
trigeminal nucleus and in parts of the cerebellum (21). Hetero-
oligomerization of the 5HT1A with the GABAB2 and GPR26
receptors may be of interest because all of these receptors are
widely distributed throughout the cortex and may therefore
share some regions of overlap (22–24). The physiological rele-
vance of the hetero-oligomerization of 5HT1A receptor with the
EDG1 and EDG3 receptors is not clear because no detailed
studies have been carried out on the distribution of the latter
receptors within the brain. However, the interactions observed
between the 5HT1A and EDG3 receptors are not likely to occur
in vivo because the relative expression levels of the latter are
relatively low in the brain with the highest levels observed in
peripheral tissues such as lung and heart (25, 26).
Supporting evidence for oligomerization of endogenously ex-
pressed GPCRs comes from Western blot studies of brain tis-
sues revealing the presence of high molecular weight immuno-
reactive forms of the dopamine D2 receptor (27) and the A1
adenosine receptor (28). More recently an immunoelectron mi-
croscopy study showed that CCR5 and CXCR4 receptors are
clustered and closely apposed on microvilli and in trans-Golgi
vesicles of human macrophages and T cells (29). The strongest
evidence comes from studies showing that GABABR1 and GAB-
ABR2 receptors could be co-immunoprecipitated from rat cortex
(9).
This is the first study in which the phenomenon of GPCR
oligomerization has been investigated using a large number of
diverse receptor subtypes. Interestingly, all of the receptors
tested were capable of forming hetero-oligomers when co-ex-
pressed in tissue culture cells suggesting that this might be a
general characteristic of these receptors. These findings high-
light the importance for further studies to investigate the oc-
currence of GPCR hetero-oligomerization in tissues and cells
where they are endogenously expressed. Such studies will help
to establish the physiological role of such complexes in GPCR
function.
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